A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia

NCT00129623 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Post-Menopausal Osteopenia

Interventions

DRUG: Placebo
DRUG: ibandronate [Bonviva/Boniva]

Sponsor

Hoffmann-La Roche